The animal core provides a central mechanism by which consistent, high quality and cost effective access to important animal models is provided. Specific Objectives: 1a) Production, husbandry and genotyping of CFTR knockout mice. 1b) Production, husbandry and genotyping of mice with targeted mutations related to immune function or inflammation. 1c) Generation of new transgenic mice. 2) Assist investigators in the selection of mutant mice and train investigators in their appropriate use as models for gene therapy, or lung infection/inflammation relevant to CF and gene therapy of CF. 3) Purchase and provide small animals for pilot gene therapy experiments. 4) Provide baboons (or other relevant primates) for selected projects, to facilitate the acquisition of pre-clinical data in preparation for human trials. Objectives 1 and 2 are central to the functions of this core, since these objectives provide important mouse models for studies related to gene transfer to the lung and chronic inflammation and injury in the lung, as seen in CF. Objective 4 is an important intermediate step before moving potentially toxic or high risk approaches into human trials, which type of studies justify the use and expense of primates. Objective 3 provides limited numbers of normal mice or rabbits to the pilot projects. These objectives address the major demands for animal core services during the current period, focus on the high priority given to CF related work and develop new mouse mutants to address a major problem encountered in gene transfer studies, the immune and inflammatory response to vector and/or transgene.

Project Start
1999-08-20
Project End
1999-12-31
Budget Start
Budget End
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Murnane, R; Zhang, X B; Hukkanen, R R et al. (2011) Myelodysplasia in 2 pig-tailed macaques (Macaca nemestrina) associated with retroviral vector-mediated insertional mutagenesis and overexpression of HOXB4. Vet Pathol 48:999-1001
Metzger, Michael J; McConnell-Smith, Audrey; Stoddard, Barry L et al. (2011) Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template. Nucleic Acids Res 39:926-35
Miller, A D; Metzger, M J (2011) APOBEC3-mediated hypermutation of retroviral vectors produced from some retrovirus packaging cell lines. Gene Ther 18:528-30
Halbert, C L; Metzger, M J; Lam, S-L et al. (2011) Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production. Gene Ther 18:411-7
Kiem, Hans-Peter; Ironside, Christina; Beard, Brian C et al. (2010) A retroviral vector common integration site between leupaxin and zinc finger protein 91 (ZFP91) observed in baboon hematopoietic repopulating cells. Exp Hematol 38:819-22, 822.e1-3
Trobridge, Grant D; Wu, Robert A; Hansen, Michael et al. (2010) Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells. Mol Ther 18:725-33
Becker, P S; Taylor, J A; Trobridge, G D et al. (2010) Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector. Gene Ther 17:1244-52
Doty, Raymond T; Sabo, Kathleen M; Chen, Jing et al. (2010) An all-feline retroviral packaging system for transduction of human cells. Hum Gene Ther 21:1019-27
Enssle, Joerg; Trobridge, Grant D; Keyser, Kirsten A et al. (2010) Stable marking and transgene expression without progression to monoclonality in canine long-term hematopoietic repopulating cells transduced with lentiviral vectors. Hum Gene Ther 21:397-403
Halbert, Christine L; Madtes, David K; Vaughan, Andrew E et al. (2010) Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs. Mol Ther 18:1165-72

Showing the most recent 10 out of 176 publications